Deep Brain Stimulation for Severe Tinnitus Relief
Official title: Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)
Run by University Hospital, Grenoble · NCT04296097 · Data updated 2026-11-12
This study is testing if deep brain stimulation can help people with severe tinnitus feel better when other treatments haven't worked.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 7 (estimated) |
| Sponsor | University Hospital, Grenoble Academic / other |
| Locations | 1 site (Grenoble) |
| Status | Recruiting |
| Started | April 23, 2021 |
| Main results expected | October 2026 |
| Study ends | October 2026 |
| Registry record updated | December 16, 2024 |
| Trial ID | NCT04296097 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 75 with severe, permanent non-pulsatile tinnitus that is resistant to previous treatments.
✕Probably not a fit
Patients with vestibular dysfunction, epilepsy, or other serious health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot study evaluates the effectiveness of Deep Brain Stimulation (DBS) targeting the right operculum 3 (OP3) in patients suffering from severe, permanent, non-pulsatile tinnitus that has not responded to other treatments. The study employs a cross-over, double-blind design to assess the impact of high-frequency stimulation on tinnitus intensity and quality of life. The rationale is based on recent findings that suggest the OP3 region plays a significant role in the perception of tinnitus, and inhibiting this area may alleviate symptoms. Participants will undergo assessments using functional imaging techniques to monitor changes in brain activity related to tinnitus.
Why it matters
Potential benefit: If successful, this treatment could significantly reduce tinnitus severity and improve the quality of life for patients suffering from this debilitating condition.
How similar studies have gone: While this approach is innovative, recent studies have indicated the potential of targeting the OP3 region for tinnitus treatment, suggesting a promising avenue for further exploration.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Between 18 and 75 years old, 2. Uni or bilateral permanent non-pulsatile tinnitus, without associated vestibular pathology, with or without hearing loss, 3. Severe tinnitus resistant to treatment failure, 4. Tinnitus intensity on the Visual Analog Scale (VAS) ≥ 7, 5. Presenting a quality of life score on the Tinnitus Handicap Inventory (THI) questionnaire\> 76 (= grade 5), 6. Social security affiliates or beneficiaries of such a scheme 7. Informed and written consent signed by the patient. Exclusion Criteria: 1. Vestibular dysfunction (balance disorder), 2. Epilepsy, 3. Intercurrent serious pathology, 4. Brain tumor, 5. Contraindication to surgery or anesthesia, 6. History of cerebral infection with herpesvirus, 7. With a contraindication to the practice of MRI, MEG, Computerized Tomography (CT) scan, 8. Under anticoagulants and antiaggregants (Anti vitamin K, low molecular weight heparin, aspirin and derivatives, clopidogrel antiplatelet agents and assimilated, new oral anticoagulants (NACO)) for which a therapeutic window can not be opened within 3 months before and after the surgery, 9. Included in another therapeutic protocol, 10. Progressive dementia or psychiatric illness, 11. Presenting a suicidal risk deemed important for less than 3 months (Montgomery and Asberg depression scale (MADRS): suicidality item (item 10) score\> 2), 12. Enforced hospitalisation, 13. Pregnant, parturient or breastfeeding, lack of contraception in patients with the capacity to procreate, 14. Subject to a legal protection measure, 15. Deprived of liberty by judicial or administrative decision, 16. Isolated patient without any contact in case of emergency.
Where it's running
-
Clinatec
Grenoble, France Recruiting
Study contacts
- Study coordinator: Stéphan CHABARDES, MD, PhD
- Email: SChabardes@chu-grenoble.fr
- Phone: 33 (0)4 76 76 93 85
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Managing COMISA: adding daridorexant to CPAP may help sleep and CPAP use
This study tests whether adding daridorexant to CPAP helps people with COMISA better stick with CPAP and feel better.
-
How the body responds to exercise with low oxygen in healthy adults
Researchers test how healthy men and women respond to different exercise types while breathing air with varying oxygen levels.
-
Multitasking in anesthesia: how well do clinicians perform under pressure in a simulation
This study tests how multitasking affects anesthesiologists’ performance in a simulated setting using a crossover design.
-
PNEUMO-LIBS: Using tissue imaging and AI to explore causes of chronic lung diseases
This study tests whether multi-element tissue imaging with LIBS, plus the AI tool IFF, can help doctors understand possible causes of chronic lung diseases in adults who have had a lung biopsy.
-
How adults with type 1 diabetes experience the physical activity mode of their hybrid closed-loop insulin system.
This project asks adults with type 1 diabetes who use a hybrid closed-loop insulin system to see if the system's physical activity mode meets their needs and how satisfied they are with it.
-
Pre-operative Paramedical Consultation for Implantable Port Planning
This trial checks whether a paramedical pre-operative consultation helps patients prepare for and cope with having an implanted port placed under local anesthesia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.